The scientific literature contains several hypotheses for the pathogenesis of schizophrenia. The most widespread hypotheses for schizophrenia are the dopaminergic, serotoninergic, and glutamatergic hypotheses. There is also the suggestion that other neurochemical systems are involved in the pathogenesis of schizophrenia, particularly the GABAergic. This review considers published data on derangements of GABAergic interneurons in schizophrenia, taking account of data on post-mortem, neuroimaging, molecular-genetic, and electrophysiological research. A hypothesis for the pathogenesis of schizophrenia based on impairments to the myelination of GABAergic interneurons is proposed, these impairments leading to decreases in the numbers of intra- and interhemisphere coherent connections and the appearance of symptoms of the disease.
Similar content being viewed by others
References
M. J. Owen, A. Sawa, and P. B. Mortensen, “Schizophrenia,” Lancet, 388, No. 10039, 86–97 (2016), https://doi.org/10.1016/S0140-6736(15)01121-6.
K. L. Davis, R. S. Kahn, G. Ko, and M. Davidson, “Dopamine in schizophrenia: a review and reconceptualization,” Am. J. Psychiatry, 148, No. 11, 1474–1486 (1991), https://doi.org/10.1176/ajp.148.11.1474.
O. D. Howes and S. Kapur, “The dopamine hypothesis of schizophrenia: version III – the final common pathway,” Schizophr. Bull., 35, No. 3, 549–562 (2009), https://doi.org/10.1093/schbul/sbp006.
H. Y. Meltzer, Z. Li, Y. Kaneda, and J. Ichikawa, “Serotonin receptors: their key role in drugs to treat schizophrenia,” Prog. Neuropsychopharmacol. Biol. Psychiatry, 27, No. 7, 1159–1172 (2003), https://doi.org/10.1016/j.pnpbp.2003.09.010.
K. Yamamoto and O. Hornykiewicz, “Proposal for a noradrenaline hypothesis of schizophrenia,” Prog. Neuropsychopharmacol. Biol. Psychiatry, 28, No. 5, 913–922 (2004), https://doi.org/10.1016/j.pnpbp.2004.05.033.
K. Nakazawa, V. Zsiros, Z. Jiang, et al., “GABAergic interneuron origin of schizophrenia pathophysiology,” Neuropharmacology, 62, No. 3, 1574–1583 (2003), https://doi.org/10.1016/j.neuropharm.2011.01.022.
M. J. Schmidt and K. Mirnics, “Neurodevelopment, GABA system dysfunction, and schizophrenia,” Neuropsychopharmacology, 40, No. 1, 190–206 (2015), https://doi.org/10.1038/npp.2014.95.
J. Stedehouder, J. J. Couey, D. Brizee, et al., “Fast-spiking parvalbumin interneurons are frequently myelinated in the cerebral cortex of mice and humans,” Cereb. Cortex, 27, No. 10, 5001–5013 (2017), https://doi.org/10.1093/cercor/bhx203.
R. Tremblay, S. Lee, and B. Rudy, “GABAergic interneurons in the neocortex: from cellular properties to circuits,” Neuron, 91, No. 2, 260–292 (2016), https://doi.org/10.1016/j.neuron.2016.06.033.
H. Markram, M. Toledo-Rodriguez, Y. Wang, et al., “Interneurons of the neocortical inhibitory system,” Nat. Rev. Neurosci., 5, No. 10, 793–807 (2003), https://doi.org/10.1038/nrn1519.
Z. F. Kisvárday, A. Gulyas, D. Beroukas, et al., “Synapses, axonal and dendritic patterns of GABA-immunoreactive neurons in human cerebral cortex,” Brain, 113, No. 3, 793–812 (1990).
B. Rudy, G. Fishell, S. Lee, and J. Hjerling-Leffler, “Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons,” Dev. Neurobiol., 71, No. 1, 45–61 (2003), https://doi.org/10.1002/dneu.20853.
J. DeFelipe, P. L. López-Cruz, R. Benavides-Piccione, et al., “New insights into the classifi cation and nomenclature of cortical GABAergic interneurons,” Nat. Rev. Neurosci., 14, No. 3, 202–216 (2013), https://doi.org/10.1038/nrn3444.
H. Hu, J. Gan, and P. Jonas, “Interneurons. Fast-spiking, parvalbumin GABAergic interneurons: from cellular design to microcircuit function,” Science, 345, No. 6196, 1255263 (2003), https://doi.org/10.1126/science.1255263.
S. M. Williams, P. S. Goldman-Rakic, and C. Leranth, “The synaptology of parvalbumin-immunoreactive neurons in the primate prefrontal cortex,” J. Comp. Neurol., 320, No. 3, 353–369 (1992), https://doi.org/10.1002/cne.903200307.
S. R. Cobb, E. H. Buhl, K. Halasy, et al., “Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons,” Nature, 378, No. 6552, 75–78 (1995), https://doi.org/10.1038/378075a0.
R. Miles, K. Tóth, A. I. Gulyás, et al., “Differences between somatic and dendritic inhibition in the hippocampus,” Neuron, 16, No. 4, 815–823 (1996).
V. S. Sohal, F. Zhang, O. Yizhar, and K. Deisseroth, “Parvalbumin neurons and gamma rhythms enhance cortical circuit performance,” Nature, 459, No. 7247, 698–702 (2009), https://doi.org/10.1038/nature07991.
G. Buzsáki and X. J. Wang, “Mechanisms of gamma oscillations,” Annu. Rev. Neurosci., 35, 203–225 (2003), https://doi.org/10.1146/annurev-neuro-062111-150444.
M. Bartos, I. Vida, and P. Jonas, “Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks,” Nat. Rev. Neurosci., 8, No. 1, 45–56 (2007), https://doi.org/10.1038/nrn2044.
E. O. Mann and O. Paulsen, “Role of GABAergic inhibition in hippocampal network oscillations,” Trends Neurosci., 30, No. 7, 343–349 (2007), https://doi.org/10.1016/j.tins.2007.05.003.
D. Senkowski and J. Gallinat, “Dysfunctional prefrontal gamma-band oscillations reflect working memory and other cognitive deficits in schizophrenia,” Biol. Psychiatry, 77, No. 12, 1010–1019 (2015), https://doi.org/10.1016/j.biopsych.2015.02.034.
V. B. Strelets, V. Yu. Novototskii-Vlasov, and Zh. V. Golikova, “Cortical connections in schizophrenia patients with positive and negative symptoms,” Zh. Vyssh. Nerv. Deyat., 51, No. 4, 452–460 (2001).
G. Gonzalez-Burgos, R. Y. Cho, and D. A. Lewis, “Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia,” Biol. Psychiatry, 77, No. 12, 1031–1040 (2003), https://doi.org/10.1016/j.biopsych.2015.03.010.
S. Akbarian and H. S. Huang, “Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders,” Brain Res. Rev., 52, No. 2, 293–304 (2006), https://doi.org/10.1016/j.brainresrev.2006.04.001.
G. Gonzalez-Burgos, T. Hashimoto, and D. A. Lewis, “Alterations of cortical GABA neurons and network oscillations in schizophrenia,” Curr. Psychiatry Rep., 12, No. 4, 335–344 (2003), https://doi.org/10.1007/s11920-010-0124-8.
T. Hashimoto, D. Arion, T. Unger, et al., “Alterations in GABArelated transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia,” Mol. Psychiatry, 13, No. 2, 147–161 (2003), https://doi.org/10.1038/sj.mp.4002011.
S. Heckers, D. Stone, J. Walsh, et al., “Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia,” Arch. Gen. Psychiatry, 59, No. 6, 521–529 (2003).
S. Akbarian, J. J. Kim, S. G. Potkin, et al., “Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics,” Arch. Gen. Psychiatry, 52, No. 4, 258–266 (2003).
T. Hashimoto, D. W. Volk, S. M. Eggan, et al., “Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia,” J. Neurosci., 23, No. 15, 6315–6326 (2003).
J. F. Enwright III, Z. Huo, D. Arion, et al., “Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia,” Mol. Psychiatry, 23, No. 7, 1606–1613 (2017), https://doi.org/10.1038/mp.2017.216.
A. J. Pocklington, E. Rees, J. T. Walters, et al., “Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia,” Neuron, 86, No. 5, 1203–1214 (2015), https://doi.org/10.1016/j.neuron.2015.04.022.
D. A. Lewis, A. A. Curley, J. R. Glausier, and D. W. Volk, “Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia,” Trends Neurosci., 35, No. 1, 57–67 (2003), https://doi.org/10.1016/j.tins.2011.10.004.
S. Pajevic, P. J. Basser, and R. D. Fields, “Role of myelin plasticity in oscillations and synchrony of neuronal activity,” Neuroscience, 276, 135–147 (2014), https://doi.org/10.1016/j.neuroscience.2013.11.007.
S. A. Anderson, O. Marin, C. Horn, et al., “Distinct cortical migrations from the medial and lateral ganglionic eminences,” Development, 128, No. 3, 353–363 (2003).
W. He, C. Ingraham, L. Rising, et al., “Multipotent stem cells from the mouse basal forebrain contribute GABAergic neurons and oligodendrocytes to the cerebral cortex during embryogenesis,” J. Neurosci., 21, No. 22, 8854–8862 (2003).
K. Letinic, R. Zoncu, and P. Rakic, “Origin of GABAergic neurons in the human neocortex,” Nature, 417, No. 6889, 645–649 (2002), https://doi.org/10.1038/nature00779.
G. Xu, K. G. Broadbelt, R. L. Haynes, et al., “Late development of the GABAergic system in the human cerebral cortex and white matter,” J. Neuropathol. Exp. Neurol., 70, No. 10, 841–858 (2011), https://doi.org/10.1097/NEN.0b013e31822f471c.
A. Voronova, S. A. Yuzwa, B. S. Wang, et al., “Migrating interneurons secrete fractalkine to promote oligodendrocyte formation in the developing mammalian brain,” Neuron, 94, No. 3, 500–516.e9 (2017), https://doi.org/10.1016/j.neuron.2017.04.018.
D. Orduz, P. P. Maldonado, M. Balia, et al., “Interneurons and oligodendrocyte progenitors form a structured synaptic network in the developing neocortex,” eLife, 4 (2015), https://doi.org/10.7554/eLife.06953.
R. Káradóttir, P. Cavelier, L. H. Bergersen, and D. Attwell, “NMDA receptors are expressed in oligodendrocytes and activated in ischaemia,” Nature, 438, No. 7071, 1162–1166 (2005), https://doi.org/10.1038/nature04302.
M. Zonouzi, J. Scafidi, P. Li, et al., “GABAergic regulation of cerebellar NG2 cell development is altered in perinatal white matter injury,” Nat. Neurosci., 18, No. 5, 674–682 (2015), https://doi.org/10.1038/nn.3990.
C. Le Magueresse and H. Monyer, “GABAergic interneurons shape the functional maturation of the cortex,” Neuron, 77, No. 3, 388–405 (2013), https://doi.org/10.1016/j.neuron.2013.01.011.
P. Somogyi and I. Soltész, “Immunogold demonstration of GABA in synaptic terminals of intracellularly recorded, horseradish peroxidase-filled basket cells and clutch cells in the cat’s visual cortex,” Neuroscience, 19, No. 4, 1051–1065 (1986).
J. DeFelipe, S. H. Hendry, and E. G. Jones, “A correlative electron microscopic study of basket cells and large GABAergic neurons in the monkey sensory-motor cortex,” Neuroscience, 17, No. 4, 991–1009 (1986).
W. Y. Ong, T. T. Yeo, V. J. Balcar, and L. J. Garey, “A light and electron microscopic study of GAT-1-positive cells in the cerebral cortex of man and monkey,” J. Neurocytol., 27, No. 10, 719–3083 (1998).
S. H. Hendry, C. R. Houser, E. G. Jones, and J. E. Vaughn, “Synaptic organization of immunocytochemically identified GABA neurons in the monkey sensory-motor cortex,” J. Neurocytol., 12, No. 4, 639– 660 (1983).
L. Seress, A. I. Gulyás, I. Ferrer, et al., “Distribution, morphological features, and synaptic connections of parvalbumin- and calbindin D28k-immunoreactive neurons in the human hippocampal formation,” J. Comp. Neurol., 337, No. 2, 208–230 (1993).
K. D. Micheva, D. Wolman, B. D. Mensh, et al., A large fraction of neocortical myelin ensheathes axons of local inhibitory neurons,” eLife, 5, e15784 (2016), https://doi.org/10.7554/eLife.15784.
A. M. Butt, N. Hamilton, P. Hubbard, et al., “Synantocytes: the fifth element,” J. Anat., 207, No. 6, 695–706 (2005), https://doi.org/10.1111/j.1469-7580.2005.00458.x.
J. J. Boulanger and C. Messier, “Oligodendrocyte progenitor cells are paired with GABA neurons in the mouse dorsal cortex: Unbiased stereological analysis,” Neuroscience, 362, 127–140 (2017), https://doi.org/10.1016/j.neuroscience.2017.08.018.
E. Boda and A. Buffo, “Beyond cell replacement: unresolved roles of NG2-expressing progenitors,” Front. Neurosci., 8, 122 (2014), https://doi.org/10.3389/fnins.2014.00122.
M. Inan, M. Zhao, M. Manuszak, et al., “Energy deficit in parvalbumin neurons leads to circuit dysfunction, impaired sensory gating and social disability,” Neurobiol. Dis., 93, 35–46 (2016), https://doi.org/10.1016/j.nbd.2016.04.004.
N. A. Uranova, M. F. Casanova, N. M. DeVaughn, et al., “Ultrastructural alterations of synaptic contacts and astrocytes in postmortem caudate nucleus of schizophrenic patients,” Schizophr. Res., 22, No. 1, 81– 83 (1996).
N. A. Uranova, D. Orlovskaya, O. V. Vikhreva, et al., “Electron microscopy of oligodendroglia in severe mental illness,” Brain Res. Bull., 55, No. 5, 597–610 (2001).
N. A. Uranova, D. D. Orlovskaia, O. V. Vikhreva, et al., “Morphometric assessment of ultrastructural plastic rearrangements in the brain in endogenous psychoses (responses of the oligodendroglia),” Vestn. Ross. Akad. Med. Nauk, 7, 42–48 (2001).
N. A. Uranova, O. V. Vikhreva, V. I. Rachmanova, and D. D. Orlovskaya, “Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study,” Schizophr. Res. Treatment, 325789 (2011), https://doi.org/10.1155/2011/325789.
O. V. Vikhreva, V. I. Rakhmanova, D. D. Orlovskaya, and N. A. Uranova, “Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: A post-mortem morphometric study,” Schizophr. Res., 177, No. 1–3, 28–36 (2016), https://doi.org/10.1016/j.schres.2016.04.023.
O. V. Vikhreva, V. I. Rakhmanova, D. D. Orlovskaya, and N. A. Uranova, “Ultrastructural pathology of oligodendrocytes in the white matter in relapsing-progressive schizophrenia and the role of the microglia,” Zh. Nevrol. Psikhiat., 118, No. 5, 69–74 (2018), https://doi.org/10.17116/jnevro20181185169.
N. A. Uranova, N. S. Kolomeets, O. V. Vikhreva, et al., “Ultrastructural pathology of myelin fibers in schizophrenia,” Zh. Nevrol. Psikhiat., 113, No. 9, 63–69 (2013).
C. L. Beasley, Z. J. Zhang, I. Patten, and G. P. Reynolds, “Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins,” Biol. Psychiatry, 52, 708–715 (2002).
V. M. Vostrikov, N. A. Uranova, and D. D. Orlovskaya, “Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders,” Schizophr. Res., 94, 273–280 (2007), https://doi.org/10.1016/j.schres.2007.04.014.
S. Kim and M. J. Webster, “Correlation analysis between genomewide expression profi les and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders,” Mol. Psychiatry, 15, 326–336 (2010), https://doi.org/10.1038/mp.2008.99.
T. White, V. A. Magnotta, H. J. Bockholt, et al., “Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study,” Schizophr. Bull., 37, No. 1, 222–232 (2011), https://doi.org/10.1093/schbul/sbp088.
P. Alvarado-Alanis, P. León-Ortiz, F. Reyes-Madrigal, et al., “Abnormal white matter integrity in antipsychotic-naive first-episode psychosis patients assessed by a DTI principal component analysis,” Schizophr. Res., 162, No. 1–3, 14–21 (2015), https://doi.org/10.1016/j.schres.2015.01.019.
Author information
Authors and Affiliations
Corresponding author
Additional information
V. M. Vostrikov is deceased
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 119, No. 8, Iss. 1, pp. 124–129, August, 2019.
Rights and permissions
About this article
Cite this article
Vostrikov, V.M. Neuromorphological Aspects of the GABAergic Hypothesis of the Pathogenesis of Schizophrenia. Neurosci Behav Physi 50, 663–668 (2020). https://doi.org/10.1007/s11055-020-00952-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-020-00952-9